Paper TrailKOREA
Why Korean and U.S. stocks moved, checked against filings
· Updated

Mercury Hits Limit-Up on a Filing; Pharmicell Rises 29.97% With No Filing at All

Mercury's third-quarter preliminary results were filed on DART. Pharmicell's jump rests on preclinical news reports with no company filing, and Daedong Metal slipped on its first day under an investment warning.

Mercury Hits Limit-Up on a Filing; Pharmicell Rises 29.97% With No Filing at All

Selection: three stocks on the regular-session close basis of Nov 9, 2026 (two limit-up, one pullback after two limit-up days), data as of 16:30 KST.

fiber optic cable

Seoul — The KOSDAQ (tech- and small-cap-heavy market) fell 0.82% to 638.97 and the KOSPI fell 0.81% to 5018.85. Mercury (100590) and Pharmicell (323990) both closed at the 30% daily limit (상한가), but only Mercury's rise is backed by a filing on DART, Korea's official disclosure system. Daedong Metal (020400), which rose 81.9% over five days, slipped 2.28% as an investment-warning designation took effect.

At a glance

Stock Why it rose Nature Basis Overheating What to check next
Mercury (100590) Q3 swing to operating profit Substance, one-off Filing 0/4, normal Whether profit holds in Q4
Pharmicell (323990) Solid-tumor CAR-T preclinical data Expectation Reports only 1/4, caution A company filing on clinical plans
Daedong Metal (020400) Pullback after two limit-up days Expectation Reports only 3/4, strong overheating Trading value during the warning

Mercury: limit-up on a Q3 return to profit (filing exists)

Mercury recent price and volume

Mercury closed at 4,400 won, up 29.99%, after turning profitable in the third quarter. According to DART, the company filed a fair-disclosure preliminary consolidated earnings report today. Money Today reported Q3 consolidated revenue of 38.2 billion won and operating profit of about 4 billion won, a return to profit, and Asia Economy said operating profit rose 198% from the prior quarter. Money Today attributed the growth to the optical-cable business. We classify the filing as positive.

The stock had been weak, though: it is 29.6% below its October 2 close and 61.1% below its 52-week high. It was already at the limit at 1:30 p.m., so the close matched the intraday move. Trading value was 10.2 billion won against a market cap of 75.4 billion won. Sell orders at the close were zero and buy orders stood at 87,406 shares. CBC News said optical-communication stocks rose together.

On the overheating check Mercury shows 0/4 signals: RSI 46.8, 0.8% below its 20-day average, volume 4.5 times normal, and 8.5% below its 200-day line. It passes 1 of 6 fundamental checks, and revenue growth is -6.4%, so whether the profit is one-off is the open question. To judge whether the move lasts, watch whether Q4 operating profit stays positive and whether revenue turns from decline to growth. The reported next-generation telecom equipment orders have not been confirmed by a company contract filing.

Pharmicell: limit-up on preclinical CAR-T data (no company filing)

Pharmicell recent price and volume

Pharmicell closed at 4,835 won, up 29.97%, after solid-tumor CAR-T preclinical results were presented at the SITC 2026 conference. The company filed nothing in the past seven days. Korea Economic Daily reported complete remission in a liver cancer model, and The Pharma News reported a 100% complete remission rate in both sexes in a mid-dose single administration. These are animal results and do not show effect in people.

The stock had risen 24.9% over two days and 20.9% over five days, and volume was 38.6 times normal on 13.7 billion won of trading value. It shows 1/4 overheating signals (caution): 19.6% above its 20-day average, but 56.0% below its 52-week high and 20.5% below its 200-day line. It passes 1 of 3 known fundamental checks. Buy orders at the limit stood at 70,205 shares, and foreign investors were net buyers of 14,451 shares on Nov 6. To judge the move, look for a company filing on clinical entry plans and whether trading value holds the next day.

Daedong Metal: down 2.28% on the first day of the warning

Daedong Metal recent price and volume

Daedong Metal closed at 3,635 won, down 2.28%. It hit the limit on Nov 4 (+29.85%) and Nov 5 (+29.9%), rising 81.9% in five days, and Nov 9 was the first day under an investment-warning designation. It has filed nothing in the past seven days. Moneystorm attributed an earlier move to strong group-company orders, but the company has not confirmed that. At 1:30 p.m. the stock was up 18.55% at 4,410 won, and it gave back all of that by the close.

It shows 3/4 overheating signals (strong overheating): RSI 76.5, 50.5% above its 20-day average, and volume 9.1 times normal. It is 55.1% below its 52-week high, passes 1 of 6 fundamental checks, and revenue growth is -5.8%. Watch whether trading value stays high during the warning period and whether the company confirms the orders in a filing. On Nov 6, foreign investors were net sellers of 13,578 shares and individuals net buyers of 13,136.

What happened to stocks we covered earlier

Stock Verdict then Close at article Close Nov 9 Change
Hanjin Kal Filing 175,200 208,000 +18.7%
Proteina Filing 52,700 58,100 +10.2%
Daedong Metal Reports 3,345 3,635 +8.7%
Hansak Reports 3,600 3,630 +0.8%
Kleannara Reports 1,779 1,767 -0.7%
Elice Unexplained 70,800 65,100 -8.1%
Duksung Unexplained 3,590 3,265 -9.1%
Younggwang Listing 21,700 9,660 -55.5%

Both stocks backed by filings rose, while the two with no confirmed reason fell 8% to 9%. Report-only stocks ranged from -0.7% to +8.7%. Younggwang, a recent listing, has lost more than half its value.

FAQ

Why did Mercury stock go up?

Q3 swing to operating profit. Evidence: Filing. What to check next: 0/4, normal.

Why did Pharmicell stock go up?

Solid-tumor CAR-T preclinical data. Evidence: Reports only. What to check next: 1/4, caution.

Why did Daedong Metal stock go up?

Pullback after two limit-up days. Evidence: Reports only. What to check next: 3/4, strong overheating.

← Latest · Daily movers archive